Hamilton Thorne Ltd (HTLZF) 0.1770 $HTLZF Hamilton

New Post Public Reply Private Reply Replies (0) Message Board

Jun 7, 2016 at 10:02 PM

Hamilton Thorne Ltd (HTLZF) 0.1770 $HTLZF

Hamilton Thorne Announces Operational and Financial Results for the Quarter Ended March 31, 2016
Marketwire Canada - Tue May 24, 7:30AM CDT
BEVERLY, MA and TORONTO, ON--(Marketwired - May 24, 2016) - Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the assisted reproductive technologies (ART) and developmental biology research markets, today reported operational and financial results for the quarter ended March 31, 2016.
HTL.VN: 0.220 (unch)

Hamilton Thorne to Present at the 2016 Bloom Burton & Co. Healthcare Investor Conference
Marketwire Canada - Thu Apr 28, 4:30PM CDT
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the ART (Assisted Reproductive Technologies), regenerative medicine and developmental biology research markets, today announced that David Wolf, President and CEO of Hamilton Thorne will present at the 2016 Bloom Burton & Co. Healthcare Investor Conference at the Sheraton Centre Toronto Hotel on May 3, 2016 at 3:00 p.m. Eastern Time.
HTL.VN: 0.220 (unch)

Hamilton Thorne Reports Record Revenue and 20% Net Income Growth for Year Ended December 31, 2015
Marketwire Canada - Mon Apr 25, 8:03AM CDT
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the ART (Assisted Reproductive Technologies), regenerative medicine and developmental biology research markets, today reported operational and financial results for the fourth quarter and year-ended December 31, 2015.
HTL.VN: 0.220 (unch)

Hamilton Thorne to Present at The MicroCap Conference in Toronto Ontario
Marketwire Canada - Thu Mar 31, 12:00PM CDT
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today announced that David Wolf, President and CEO of Hamilton Thorne, will be presenting at The MicroCap Conference on Monday, April 11 at 3:30 p.m. (EDT) at the Philadelphia Hilton Toronto in Toronto, Ontario.
HTL.VN: 0.220 (unch)

Hamilton Thorne to Present at the 2015 LD Micro Main Event
Marketwire Canada - Mon Nov 23, 3:05PM CST
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today announced that David Wolf, President and CEO of Hamilton Thorne will be presenting at the LD Micro Main Event (www.ldmicro.com), on Wednesday, December 2 at 5:00 pm Pacific Time (8:00 pm Eastern Time), at the Luxe Sunset Bel Air Hotel in Los Angeles, CA.
HTL.VN: 0.220 (unch)

Hamilton Thorne Reports 44% Net Income Growth for the Quarter Ended September 30, 2015
Marketwired - Wed Nov 18, 3:15PM CST
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today reported operational and financial results for the quarter and nine-months ended September 30, 2015.
HTL.VN: 0.220 (unch)

Hamilton Thorne Strengthens Management Team-Appoints Keith F. Edwards as Senior Vice President and General Manager
Marketwire Canada - Tue Nov 17, 3:37PM CST
Hamilton Thorne Ltd. (TSX VENTURE: HTL) ("Hamilton Thorne" or the "Company"

, a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today announced the hiring of Keith F. Edwards as Senior Vice President & General Manager of Hamilton Thorne, Inc., reporting to CEO and President David Wolf.
HTL.VN: 0.220 (unch)

Hamilton Thorne Strengthens Management Team -- Appoints Keith F. Edwards as Senior Vice President and General Manager
Marketwired - Tue Nov 17, 3:37PM CST
Hamilton Thorne Ltd. (TSX VENTURE: HTL) ("Hamilton Thorne" or the "Company"

, a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today announced the hiring of Keith F. Edwards as Senior Vice President & General Manager of Hamilton Thorne, Inc., reporting to CEO and President David Wolf.
HTL.VN: 0.220 (unch)

Hamilton Thorne Announces Exercises of Warrants Yielding Gross Proceeds of CDN $1.1 Million
Marketwire Canada - Mon Nov 16, 3:55PM CST
Hamilton Thorne Ltd. (TSX VENTURE: HTL) ("Hamilton Thorne" or the "Company"

, a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today announced the exercises of a total of 5,720,500 warrants issued in November 2014 at an exercise price of CDN$0.20 per share yielding gross proceeds of CDN$1,144,100 (approx. US$850,000).
HTL.VN: 0.220 (unch)

Hamilton Thorne to Present at The MicroCap Conference
Marketwire Canada - Fri Oct 30, 3:10PM CDT
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today announced that David Wolf, President and CEO of Hamilton Thorne, will be presenting at The MicroCap Conference (http://www.microcapconf.com) on Thursday, November 5th at 10:30 a.m. (EST) at the Philadelphia Marriott Downtown in Philadelphia, PA.
HTL.VN: 0.220 (unch)

Hamilton Thorne Announces Extension of Its Committed Line of Credit to November 2017
Marketwire Canada - Mon Oct 05, 4:01PM CDT
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today announced that it reached agreement with Commerce Bank and Trust to extend its committed line of credit from October 2016 to November 2017.
HTL.VN: 0.220 (unch)

Hamilton Thorne Announces Continued Revenue and Net Income Growth for the Quarter Ended June 30, 2015
Marketwire Canada - Wed Aug 19, 3:39PM CDT
Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today reported operational and financial results for the quarter ended June 30, 2015.
HTL.VN: 0.220 (unch)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Faith and Resilience in China: The Legacy of the Long March

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Antheia Secures $80M for Critical Medicine Onshoring

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Lundbeck's Board Leadership Transitions into New Era

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Tomorrowland's Shanghai Return: An Electri-Lifesaver

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

AEVEX Faces 48-Hour Deadline for Investor Class Action

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

ASTS Faces a Legal Countdown – Investors Take Note

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

UEG's New Advisory Board: Elevating Patient Voices

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...